Reliq Health Technologies, Inc. Announces Exercise of Warrants with Gross Proceeds of Over $2 Million
HAMILTON, Ontario, Nov. 08, 2019 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a […]
HAMILTON, Ontario, Nov. 08, 2019 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a […]
DAYTONA BEACH, Fla., Nov. 08, 2019 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (the “Company” or “PINE”) announced today […]
ALAMEDA, Calif., Nov. 08, 2019 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE American: OCX), a molecular diagnostics company providing actionable answers […]
BOSTON, Nov. 08, 2019 (GLOBE NEWSWIRE) — Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapies for the […]
HOUSTON, Nov. 08, 2019 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense […]
Announced Positive Initial Results from the Ongoing ENDYMION trial with OV935 (Soticlestat) in Rare Epilepsies; Sustained and Progressively-Improving Median Seizure […]
CAMBRIDGE, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and […]
Part A comprises NSCLC patients with all levels of PD-L1 expression, being an all comer trialPreliminary Overall Response Rate (ORR) […]
– Compelling preclinical data presented at the European Society of Gene and Cell Therapy Annual Congress demonstrates the potential for […]
STOUGHTON, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being […]